Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
BJP Stock Overview
Beit Jala Pharmaceutical Company engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.
Beit Jala Pharmaceutical Company Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | د.أ2.79 |
52 Week High | د.أ2.90 |
52 Week Low | د.أ2.57 |
Beta | -0.054 |
1 Month Change | 0% |
3 Month Change | 4.89% |
1 Year Change | 8.56% |
3 Year Change | 15.77% |
5 Year Change | 16.25% |
Change since IPO | 82.47% |
Recent News & Updates
Shareholder Returns
BJP | PS Pharmaceuticals | PS Market | |
---|---|---|---|
7D | 0% | 1.7% | 0.5% |
1Y | 8.6% | -14.2% | 11.2% |
Return vs Industry: BJP exceeded the PS Pharmaceuticals industry which returned -13.9% over the past year.
Return vs Market: BJP underperformed the PS Market which returned 11.2% over the past year.
Price Volatility
BJP volatility | |
---|---|
BJP Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 5.4% |
Market Average Movement | 3.1% |
10% most volatile stocks in PS Market | 6.1% |
10% least volatile stocks in PS Market | 1.8% |
Stable Share Price: Insufficient data to determine BJP's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine BJP's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1933 | 225 | n/a | https://www.beitjalapharma.com |
Beit Jala Pharmaceutical Company engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority. The company provides its products in various forms, such as tablets, capsules, powders, oral drops, solutions, suspensions, syrups, creams, gels, lotions, and suppositories. It also offers medicated shampoos; and sterile products, including eye, ear, and nose drops and ointments.
Beit Jala Pharmaceutical Company Fundamentals Summary
BJP fundamental statistics | |
---|---|
Market Cap | د.أ19.53m |
Earnings (TTM) | د.أ995.27k |
Revenue (TTM) | د.أ10.00m |
19.6x
P/E Ratio2.0x
P/S RatioIs BJP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BJP income statement (TTM) | |
---|---|
Revenue | د.أ10.00m |
Cost of Revenue | د.أ7.05m |
Gross Profit | د.أ2.95m |
Other Expenses | د.أ1.96m |
Earnings | د.أ995.27k |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.14 |
Gross Margin | 29.53% |
Net Profit Margin | 9.95% |
Debt/Equity Ratio | 28.3% |
How did BJP perform over the long term?
See historical performance and comparison